Fundz
You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →

One04 Therapeutics secures undisclosed funding from D11Z.Ventures to accelerate the development of CPV-104, a promising treatment for complement-mediated diseases.

PRIVATESep 15, 2026•1 day ago

Round Type

Venture - Series Unknown

Freiburg Im BreisgauBiotechnologyTherapeuticsPharmaceuticalBiopharma

Investors

D11 Z.Ventures

Description

One04 Therapeutics GmbH & Co. KG has announced its launch as a clinical-stage biopharmaceutical company with Phase 1 results for CPV-104. The company has secured funding from D11Z.Ventures to facilitate expansion into kidney diseases and dry AMD. This funding will support key development milestones in 2026 and 2027

Company Information

Company

One04 Therapeutics GmbH & KG

Location

Freiburg Im Breisgau, Baden Württemberg, Germany

About

One04 Therapeutics GmbH & Co. KG is a clinical-stage biopharmaceutical company focused on developing CPV-104, a first-in-class recombinant human Factor H candidate. The company aims to treat a variety of complement-mediated diseases, with its current focus on kidney diseases and dry age-related macular degeneration. One04 is dedicated to accelerating the development of its therapeutic candidates through strategic independence and optimal operational focus.

Don't miss One04 Therapeutics GmbH & KG's next move

Get an email the moment One04 Therapeutics GmbH & KG raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for One04 Therapeutics GmbH & KG's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

One04 Therapeutics GmbH & KG raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.